Creative Medical Technology Holdings (CELZ) Divestments (2023 - 2024)
Creative Medical Technology Holdings' (CELZ) quarterly Divestments came in at $6.5 million in Q1 2024, up 29.44% year-over-year from $5.0 million in Q2 2023, and down 62.42% quarter-over-quarter from $17.4 million in Q4 2023.
Powered by 
Analysis
Creative Medical Technology Holdings (CELZ) Divestments (2023 - 2024) Analysis & Trends
Creative Medical Technology Holdings (CELZ) has reported Divestments for 2 consecutive years, with $6.5 million the latest figure, recorded in Q1 2024.
- On a quarterly basis, Divestments rose 29.44% year-over-year to $6.5 million in Q1 2024; TTM through Dec 2024 was $6.5 million, a 75.3% decrease from a year earlier, with the FY2024 full-year figure at $6.5 million, down 75.3% from the prior year.
- Divestments was $6.5 million for Q1 2024 at Creative Medical Technology Holdings, down from $17.4 million in the prior quarter.
- Over five years, Divestments peaked at $17.4 million in Q4 2023 and troughed at $11133.0 in Q2 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.60 Bn | 9.76 Bn | 112.79 Mn | - |
| 2 | CRISPR Therapeutics AG | 5.39 Bn | 5.39 Bn | - | - |
| 3 | Iovance Biotherapeutics | 3.98 Bn | 3.68 Bn | 55.72 Mn | - |
| 4 | Legend Biotech | 3.97 Bn | 3.00 Bn | 251.50 Mn | - |
| 5 | uniQure | 3.09 Bn | 3.09 Bn | 5.49 Mn | - |
| 6 | Beam Therapeutics | 3.06 Bn | 3.06 Bn | - | - |
| 7 | Precigen | 2.54 Bn | 2.54 Bn | 52.17 Mn | - |
| 8 | Sarepta Therapeutics | 2.38 Bn | 1.58 Bn | 251.87 Mn | - |
| 9 | Vericel | 2.06 Bn | 1.89 Bn | 56.40 Mn | - |
| 10 | Creative Medical Technology Holdings | 1.48 Mn | 1.50 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2024 | 6.52 Mn |
| Dec 31, 2023 | 17.35 Mn |
| Sep 30, 2023 | 4.00 Mn |
| Jun 30, 2023 | 11,133.00 |
| Mar 31, 2023 | 5.04 Mn |